Skip to main content

GOLDMAN SACHS GROUP INC

Position in CTMX — CytomX Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in CTMX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$6,861,242
-$3,622,378 QoQ
Shares Held
1,459,839
-40.7% QoQ
Ownership
0.671%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 178 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CTMX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. CTMX ranks #161 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CTMX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,861,242 1,459,839
2025-12-31 $10,483,620 2,460,944
2025-09-30 $1,428,331 447,753
2025-06-30 $33,319 14,678
2025-03-31 $39,253 61,719
2024-09-30 $14,160 12,000
2024-06-30 $133,348 109,302
2024-03-31 $640,688 293,894
2023-06-30 $17,573 10,217
2023-03-31 $20,229 13,397
2022-12-31 $166,277 103,924
2022-09-30 $193,854 133,693
2022-06-30 $343,201 187,542
2022-03-31 $2,025,432 758,589
2021-12-31 $2,757,975 636,946
2021-09-30 $5,645,140 1,109,065
2021-06-30 $6,026,267 952,017
2021-03-31 $1,616,358 209,102
2020-12-31 $1,489,790 227,449
2020-09-30 $1,860,822 279,823
2020-06-30 $2,314,448 277,845
2020-03-31 $1,058,828 138,048